Pressemeddelelse fra LEO Pharma
Birgitta Stymne Göransson has worked as non-executive Boardmember, Chairman and Committee Chair of several boards and audit committees and has more than 25 years of experience in medtech and IT/tech as well as consulting, consumer retail and branded goods.
Birgitta Stymne Göransson’s current chairmanships include BCB Medical Oy and Industrifonden in Sweden as well as Chair of the Audit Committees of Elekta AB and Pandora AS. In her previous executive roles, she has among other worked as Industrial Advisor to Ratos AB, and held positions as Chief Executive at Memira Holding AB and Semantix Group AB.
Olivier Bohuon, Chairman of the Board of Directors at LEO Pharma A/S, says: “We are pleased to welcome Birgitta Stymne Göransson to the Board of Directors. With her broad industry insights and deep financial experience from both public and private companies, she will play an important role in the realization of LEO Pharma’s ambitious growth strategy.”
Birgitta Stymne Göransson holds an MBA from Harvard Business School, MA, USA as well as a M.Sc. in Chemical Engineering and Biotechnology from the Royal Institute of Technology in Sweden.
Kontakt:
Trine Juul Wengel
Global External Communications, LEO Pharma A/S
Tel.: (+45) 20732037
Email: tewdk@leo-pharma.com
Læs hele pressemeddelelsen på Via Ritzau her: https://via.ritzau.dk/pressemeddelelse/birgitta-stymne-goransson-elected-member-of-leo-pharmas-board-of-directors?releaseId=13583063
